MENU

PSNL Stock Personalis (PSNL, $3.38) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 9, 2025

A.I.dvisor
at Tickeron.com
Loading...
PSNL - Personalis
MACD signal
Bullish Trend
Odds of UP Trend
Tickeron
MACD signal
Price: $3.38
Daily change: +$0.38 (+12.67%)
Daily volume: 1.1M
Capitalization: $299.4M
Industry: Medical Specialties
This is a Bullish indicator signaling PSNL's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 49 similar cases where PSNL's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

PSNL's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for PSNL turned positive on April 09, 2025. Looking at past instances where PSNL's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 73 cases where PSNL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PSNL advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

PSNL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PSNL as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for PSNL moved below the 200-day moving average on April 07, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PSNL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PSNL entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.560) is normal, around the industry mean (23.907). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.941) is also within normal values, averaging (42.115).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PSNL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PSNL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
PSNL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
6600 Dumbarton Circle
Phone
+1 650 752-1300
Employees
225
Web
https://www.personalis.com